Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.3 EUR | +2.33% | +1.28% | -23.23% |
02-26 | Jefferies Adjusts GMO Payment’s Price Target to 11,000 Yen From 13,350 Yen, Keeps at Buy | MT |
2023 | Enpay Inc. announced that it has received ¥850 million in funding from a group of investors | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 68% by 2026.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 35.58 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-23.23% | 3.8B | - | ||
+16.69% | 90.7B | B | ||
+4.05% | 66.84B | B | ||
-7.54% | 44.13B | C- | ||
-14.31% | 27.78B | C- | ||
-1.26% | 19.61B | C+ | ||
-11.45% | 12.93B | A- | ||
-9.91% | 10.28B | C | ||
-15.07% | 9.05B | B+ | ||
+4.68% | 8.53B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3769 Stock
- 3RH Stock
- Ratings GMO Payment Gateway, Inc.